ULTRAM ER

DRUG2 trials

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions

Pain

Phase 1

A Study of ULTRAM ER at Two Dose Levels in Adolescents With Pain

CompletedNCT01586507

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Pain

Start: 2007-10-31End: 2008-09-30Updated: 2012-08-29

A Pharmacokinetic, Tolerability, and Safety Study of ULTRAM ER in Children With Pain

CompletedNCT01586494

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Pain

Start: 2007-10-31End: 2009-06-30Updated: 2012-08-29